Man Group plc - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q4 2022$3,094,492
-53.0%
305,478
-54.1%
0.01%
-64.5%
Q3 2022$6,581,000
+222.3%
665,422
+246.9%
0.03%
+244.4%
Q2 2022$2,042,000
+107.3%
191,799
+290.1%
0.01%
+200.0%
Q3 2021$985,000
-2.4%
49,165
+7.2%
0.00%
-25.0%
Q2 2021$1,009,000
-34.4%
45,857
+1.2%
0.00%
-42.9%
Q1 2021$1,539,00045,3050.01%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders